Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
HealthStream, Inc. (NASDAQ: HSTM) shares increased 7.57 percent to close at $37.82 a share Wednesday. The stock traded between $35.60 and $38.34 on volume of 176,396 shares traded. Analysts at Northland Capital have recently initiated coverage on the company with an "outperform" rating. Shares of HealthStream have gained approximately 55.0 percent year-to-date.
Find out more about HealthStream including full access to the free equity report at:
Infosys Ltd. (NYSE: INFY) shares increased 0.53 percent to close at $48.87 a share Wednesday. The stock traded between $48.78 and $49.29 on volume of 1.17 million shares traded. Analysts at Robert W. Baird have recently upgraded the company’s rating to "outperform" from "neutral". Shares of Infosys have gained approximately 15.0 percent year-to-date.
Find out more about Infosys including full access to the free equity report at:
Republic Airways Holdings Inc. (NASDAQ: RJET) shares declined 1.75 percent to close at $12.88 a share Wednesday. The stock traded between $12.62 and $12.95 on volume of 421,772 shares traded. Analysts at Imperial Capital have recently downgraded the company’s rating to "in-line" from "outperform". Shares of Republic Airways have gained approximately 125.0 percent year-to-date.
Find out more about Republic Airways including full access to the free equity report at:
Raptor Pharmaceutical Corp. (NASDAQ: RPTP) shares declined 1.77 percent to close at $13.85 a share Wednesday. The stock traded between $13.30 and $14.34 on volume of 1.09 million shares traded. Analysts at Oppenheimer have recently upgraded the company’s rating to "perform" from "outperform". Shares of Raptor Pharmaceutical have gained approximately 135.0 percent year-to-date.
Find out more about Raptor Pharmaceutical including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing
Leave a comment...